Red blood cell formation pathway

The term "Red blood cell formation pathways" refers collectively to the molecular networks that regulate the process known as erythropoiesis, which is the production and maturation of red blood cells from hematopoietic stem cells. This is not a single molecule or receptor but rather a complex biological process involving multiple signaling molecules, receptors (notably the erythropoietin receptor), transcription factors (GATA1, STAT5, KLF1, among others), hormones, vitamins, iron metabolism regulators (transferrin receptors), and growth factors. Key intracellular pathways include PI3K/AKT and JAK/STAT signaling cascades activated by cytokines like erythropoietin. Dysregulation at various points in these pathways can result in diseases such as anemia or leukemia. Drugs targeting this system—primarily recombinant forms of erythropoietin—are used therapeutically for certain anemias but carry risks if not carefully managed due to their effects on red cell mass and potential disease progression in some contexts[1][2][4][6]. Because "Red blood cell formation pathways" describes a set of processes rather than a discrete molecular target or druggable entity, it should not be considered a canonical therapeutic target itself; instead, individual components within these pathways may serve as targets for therapy or biomarker development.

Other names

erythropoiesis pathwayerythroid differentiation pathwayRBC formation pathway

Stimulation of erythropoietin receptor signaling to promote survival and proliferation of erythroid progenitors[2][6] - Modulation of transcription factors such as GATA1, STAT5, KLF1 to drive lineage commitment and maturation[1][2]